Dr. Joshua Martin Reside, MD

Dr. Reside practices at The Surgery Center at Mississippi Sports Medicine and Orthopaedic Center in Flowood, Mississippi.

Dr. Reside's NPI, 1497251482, was assigned on March 30, 2018. Dr. Reside graduated from University Of Florida College Of Medicine in 2018. Dr. Reside holds Florida license ME167762.

Dr. Reside's primary practice is The Surgery Center at Mississippi Sports Medicine and Orthopaedic Center, at 4510 Lakeland Drive, Flowood, MS 39232. The practice phone is (601) 401-4843.

Dr. Reside's primary practice is The Surgery Center at Mississippi Sports Medicine and Orthopaedic Center in Flowood, Mississippi. Dr. Reside is also affiliated with UF Health Shands Hospital. The medical group on file is UF Health Physicians. Dmand AI also links Dr. Reside to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reside practices, 2 sites in all. Vendor and product names are available with a free account.

Orthopaedic surgery is Dr. Reside's primary specialty in the NPI Registry, under taxonomy code 207X00000X. Dmand AI has Dr. Reside's licenses on file in 2 states: Florida and Mississippi.

CMS data shows 101 Medicare services from Dr. Reside across 4 procedure codes in 2024, for 60 Medicare patients. Medicare paid $5,653 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 60 Medicare patients who saw Dr. Reside in 2024. The largest group is 65 to 74, with 37 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 0.73, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reside's median patient age at 69, with 49% women.

In 2024, Dr. Reside wrote 35 Medicare Part D claims for 21 patients. 100% of them were for generic drugs. CMS names the drug for 27 of them, across 1 drug with 11 or more claims each, at $76 in total drug cost. In 2023, CMS named 43 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 48 out of 100 for Dr. Reside for performance year 2024, reported through an alternative payment model (APM). Dr. Reside accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 31 procedures of upper limb (arm) arthroscopy (minimally invasive joint repair) by Dr. Reside, more than 75% of the clinicians it reports for that procedure.

Lower limb (leg) arthroscopy (minimally invasive joint repair): 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 4 papers to Dr. Reside, published from 2014 to 2024. Dr. Reside's most frequent co-authors are Eric E. Roselli, MD, Jahanzaib Idrees, MD, MPH and Susan M. Shafii, MD.

CMS Open Payments shows 59 general payments to Dr. Reside from 9 drug and device companies from 2023 to 2025. Grants make up the largest share, 66% of the total. Arthrex, Inc. paid the most, $22,576.

Dr. Reside graduated from University Of Florida College Of Medicine in 2018.

Dr. Reside is in network with 16 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.